Shuren: LDT Reliability Critical To Precision Medicine Initiative
This article was originally published in The Gray Sheet
Executive Summary
The head of CDRH said the agency's efforts to oversee laboratory developed tests are critical to ensuring reliability of genetic tests in conjunction with the president's Precision Medicine Initiative.